Unternehmen
Abiomed, Inc

Aktueller Kurs
329.69 USD

Symbol
ABMD

ISIN
US0036541003

Börse
NASDAQ

Sektor
Health Care

Marktkapitalisierung
14.8987 Mrd. US

Branche
Health Care Equipment & Supplies

Dividendenrendite
0 %

Ausschüttungsquote
0 %

KGV
72.46

KUV (TTM)
18.42

KGVe
0.00

Kursziel
326.6 USD

Unternehmen
Abiomed, Inc

Aktueller Kurs
329.69 USD

Symbol
ABMD

ISIN
US0036541003

Börse
NASDAQ

Marktkapitalisierung
14.8987 Mrd. USD

Sektor
Health Care

Branche
Health Care Equipment & Supplies

Dividendenrendite
0 %

Ausschüttungsquote
0 %

KGV
72.46

KUV (TTM)
18.42

KGVe
0.00

Kursziel
326.6 USD

Live-Chart (verzögert)

Firmenbeschreibung

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.

Abiomed, Inc Fundamentaldaten

Jahre und Quartale beziehen sich jeweils auf das Geschäftsjahr des Unternehmens. (Das Geschäftsjahr kann ggf. vom Kalenderjahr abweichen.)

Das Geschäftsjahr von Abiomed, Inc endet im März.

Gewinn pro Jahr & Quartal (Net Income) in Mrd. USD

Q1
Apr-Jun
Q2
Jul-Sep
Q3
Okt-Dez
Q4
Jan-Mrz
Jahr
Apr-Mrz
2021 0.045 0.062 0.000 0.000 0.107
2020 0.089 0.013 0.069 0.032 0.203
2019 0.090 0.050 0.045 0.074 0.259
2018 0.037 0.025 0.013 0.037 0.112
2017 0.013 0.009 0.015 0.015 0.052
2016 0.009 0.008 0.011 0.011 0.038
2015 -0.002 0.004 0.013 0.099 0.114
2014 -0.002 0.001 0.004 0.004 0.007
2013 0.003 0.005 0.003 0.004 0.015
2012 -0.005 0.001 0.003 0.003 0.001
2011 0.000 0.000 0.000 0.000 0.000
2010 0.000 0.000 0.000 0.001 0.001

Gewinn je Aktie (EPS) pro Jahr & Quartal (non-GAAP)

Q1
Apr-Jun
Q2
Jul-Sep
Q3
Okt-Dez
Q4
Jan-Mrz
Jahr
Apr-Mrz
2021 0.58 1.01 0 0 1.59
2020 1 1.0261 1.11 0.98 4.1161
2019 0.78 0.81 0.93 1.07 3.59
2018 0.4511 0.44 0.7 0.8 2.3911
2017 0.29 0.2 0.34 0.4007 1.2307
2016 0.2 0.17 0.23 0.24 0.84
2015 -0.04 0.09 0.3 0.28 0.63
2014 -0.04 0.07 0.11 0.09 0.23
2013 0.08 0.13 0.07 0.09 0.37
2012 -0.12 0.02 0.05 0.06 0.01
2011 -0.16 -0.09 -0.02 -0.05 -0.32
2010 -0.21 -0.21 -0.12 -0.13 -0.67

Umsatz pro Jahr & Quartal in Mrd. USD

Q1
Apr-Jun
Q2
Jul-Sep
Q3
Okt-Dez
Q4
Jan-Mrz
Jahr
Apr-Mrz
2021 0.16485 0.209764 0 0 0.374614
2020 0.207666 0.204974 0.200563 0.16485 0.778053
2019 0.18001 0.181778 0.207081 0.206658 0.775527
2018 0.132468 0.132823 0.174436 0.207081 0.646808
2017 0.102995 0.102955 0.114674 0.174436 0.49506
2016 0.073432 0.076359 0.085795 0.093957 0.329543
2015 0.048811 0.051938 0.062005 0.067557 0.230311
2014 0.04267 0.044345 0.046195 0.050433 0.183643
2013 0.038783 0.037417 0.03825 0.043674 0.158124
2012 0.027355 0.029478 0.032198 0.037344 0.126375
2011 0.022002 0.023376 0.027244 0.028529 0.101151
2010 0.019913 0.020022 0.022799 0.022979 0.085713

Umsatz je Aktie pro Jahr & Quartal

Q1
Apr-Jun
Q2
Jul-Sep
Q3
Okt-Dez
Q4
Jan-Mrz
Jahr
Apr-Mrz
2021 3.58 4.56 0.00 0.00 1.69
2020 4.51 4.46 4.36 3.58 16.91
2019 3.91 3.95 4.50 4.49 16.86
2018 2.88 2.89 3.79 4.50 14.06
2017 2.29 2.29 2.55 3.88 11.00
2016 1.67 1.70 1.91 2.09 7.32
2015 1.22 1.24 1.44 1.57 5.36
2014 1.09 1.08 1.10 1.20 4.37
2013 0.92 0.89 0.93 1.07 3.86
2012 0.72 0.76 0.80 0.93 3.16
2011 0.59 0.63 0.74 0.77 2.73
2010 0.54 0.54 0.62 0.62 2.32

Gewinn-Wachstum in Prozent

Q1
Apr-Jun
Q2
Jul-Sep
Q3
Okt-Dez
Q4
Jan-Mrz
Jahr
Apr-Mrz
2021 40.22 39.53 -100.00 0.00 -47.39
2020 20.23 -85.30 429.55 -54.06 -21.62
2019 144.43 -44.34 -10.50 64.86 130.91
2018 150.85 -34.44 -45.13 174.04 115.23
2017 17.38 -31.25 73.88 -3.45 36.62
2016 -91.04 -12.69 36.46 4.20 -66.45
2015 -147.18 0.00 230.40 679.52 1446.57
2014 -146.04 0.00 314.83 -17.55 -51.04
2013 21.50 75.34 -50.92 39.42 904.28
2012 0.00 0.00 386.02 -12.12 0.00
2011 -100.00 0.00 0.00 0.00 -100.00
2010 0.00 0.00 0.00 0.00 0.00

Umsatz-Wachstum in Prozent

Q1
Apr-Jun
Q2
Jul-Sep
Q3
Okt-Dez
Q4
Jan-Mrz
Jahr
Apr-Mrz
2021 0.00 27.25 0.00 0.00 0.00
2020 0.49 -1.30 -2.15 -17.81 0.33
2019 -13.07 0.98 13.92 -0.20 19.90
2018 -24.06 0.27 31.33 18.71 30.65
2017 9.62 -0.04 11.38 52.11 50.23
2016 8.70 3.99 12.36 9.51 43.09
2015 -3.22 6.41 19.38 8.95 25.41
2014 -2.30 3.93 4.17 9.17 16.14
2013 3.85 -3.52 2.23 14.18 25.12
2012 -4.12 7.76 9.23 15.98 24.94
2011 -4.25 6.24 16.55 4.72 18.01
2010 1.69 0.55 13.87 0.79 17.08

Abiomed, Inc Fundamentaldaten

Gewinn pro Jahr & Quartal (Net Income)

Q1
Apr-Jun
Q2
Jul-Sep
Q3
Okt-Dez
Q4
Jan-Mrz
Jahr
Apr-Mrz
2021 0.045 0.062 0.000 0.000 0.107
2020 0.089 0.013 0.069 0.032 0.203
2019 0.090 0.050 0.045 0.074 0.259
2018 0.037 0.025 0.013 0.037 0.112
2017 0.013 0.009 0.015 0.015 0.052
2016 0.009 0.008 0.011 0.011 0.038
2015 -0.002 0.004 0.013 0.099 0.114
2014 -0.002 0.001 0.004 0.004 0.007
2013 0.003 0.005 0.003 0.004 0.015
2012 -0.005 0.001 0.003 0.003 0.001
2011 0.000 0.000 0.000 0.000 0.000
2010 0.000 0.000 0.000 0.001 0.001

Gewinn je Aktie (EPS) pro Jahr & Quartal (non-GAAP)

Q1
Apr-Jun
Q2
Jul-Sep
Q3
Okt-Dez
Q4
Jan-Mrz
Jahr
Apr-Mrz
2021 0.58 1.01 0 0 1.59
2020 1 1.0261 1.11 0.98 4.1161
2019 0.78 0.81 0.93 1.07 3.59
2018 0.4511 0.44 0.7 0.8 2.3911
2017 0.29 0.2 0.34 0.4007 1.2307
2016 0.2 0.17 0.23 0.24 0.84
2015 -0.04 0.09 0.3 0.28 0.63
2014 -0.04 0.07 0.11 0.09 0.23
2013 0.08 0.13 0.07 0.09 0.37
2012 -0.12 0.02 0.05 0.06 0.01
2011 -0.16 -0.09 -0.02 -0.05 -0.32
2010 -0.21 -0.21 -0.12 -0.13 -0.67

Umsatz pro Jahr & Quartal

Q1
Apr-Jun
Q2
Jul-Sep
Q3
Okt-Dez
Q4
Jan-Mrz
Jahr
Apr-Mrz
2021 0.16485 0.209764 0 0 0.374614
2020 0.207666 0.204974 0.200563 0.16485 0.778053
2019 0.18001 0.181778 0.207081 0.206658 0.775527
2018 0.132468 0.132823 0.174436 0.207081 0.646808
2017 0.102995 0.102955 0.114674 0.174436 0.49506
2016 0.073432 0.076359 0.085795 0.093957 0.329543
2015 0.048811 0.051938 0.062005 0.067557 0.230311
2014 0.04267 0.044345 0.046195 0.050433 0.183643
2013 0.038783 0.037417 0.03825 0.043674 0.158124
2012 0.027355 0.029478 0.032198 0.037344 0.126375
2011 0.022002 0.023376 0.027244 0.028529 0.101151
2010 0.019913 0.020022 0.022799 0.022979 0.085713

Umsatz je Aktie pro Jahr & Quartal

Q1
Apr-Jun
Q2
Jul-Sep
Q3
Okt-Dez
Q4
Jan-Mrz
Jahr
Apr-Mrz
2021 3.58 4.56 0.00 0.00 1.69
2020 4.51 4.46 4.36 3.58 16.91
2019 3.91 3.95 4.50 4.49 16.86
2018 2.88 2.89 3.79 4.50 14.06
2017 2.29 2.29 2.55 3.88 11.00
2016 1.67 1.70 1.91 2.09 7.32
2015 1.22 1.24 1.44 1.57 5.36
2014 1.09 1.08 1.10 1.20 4.37
2013 0.92 0.89 0.93 1.07 3.86
2012 0.72 0.76 0.80 0.93 3.16
2011 0.59 0.63 0.74 0.77 2.73
2010 0.54 0.54 0.62 0.62 2.32

Gewinn-Wachstum in Prozent

Q1
Apr-Jun
Q2
Jul-Sep
Q3
Okt-Dez
Q4
Jan-Mrz
Jahr
Apr-Mrz
2021 40.22 39.53 -100.00 0.00 -47.39
2020 20.23 -85.30 429.55 -54.06 -21.62
2019 144.43 -44.34 -10.50 64.86 130.91
2018 150.85 -34.44 -45.13 174.04 115.23
2017 17.38 -31.25 73.88 -3.45 36.62
2016 -91.04 -12.69 36.46 4.20 -66.45
2015 -147.18 0.00 230.40 679.52 1446.57
2014 -146.04 0.00 314.83 -17.55 -51.04
2013 21.50 75.34 -50.92 39.42 904.28
2012 0.00 0.00 386.02 -12.12 0.00
2011 -100.00 0.00 0.00 0.00 -100.00
2010 0.00 0.00 0.00 0.00 0.00

Umsatz-Wachstum in Prozent

Q1
Apr-Jun
Q2
Jul-Sep
Q3
Okt-Dez
Q4
Jan-Mrz
Jahr
Apr-Mrz
2021 0.00 27.25 0.00 0.00 0.00
2020 0.49 -1.30 -2.15 -17.81 0.33
2019 -13.07 0.98 13.92 -0.20 19.90
2018 -24.06 0.27 31.33 18.71 30.65
2017 9.62 -0.04 11.38 52.11 50.23
2016 8.70 3.99 12.36 9.51 43.09
2015 -3.22 6.41 19.38 8.95 25.41
2014 -2.30 3.93 4.17 9.17 16.14
2013 3.85 -3.52 2.23 14.18 25.12
2012 -4.12 7.76 9.23 15.98 24.94
2011 -4.25 6.24 16.55 4.72 18.01
2010 1.69 0.55 13.87 0.79 17.08

Abiomed, Inc Dividenden-Entwicklung

Ex-Tag Record Date Zahltag Dividende
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0
0000-00-00 0000-00-00 0000-00-00 0